143 related articles for article (PubMed ID: 25022880)
1. Molecular determinants for improved activity at PPARα: structure-activity relationship of pirinixic acid derivatives, docking study and site-directed mutagenesis of PPARα.
Lamers C; Dittrich M; Steri R; Proschak E; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2014 Aug; 24(16):4048-52. PubMed ID: 25022880
[TBL] [Abstract][Full Text] [Related]
2. Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma.
Rau O; Syha Y; Zettl H; Kock M; Bock A; Schubert-Zsilavecz M
Arch Pharm (Weinheim); 2008 Mar; 341(3):191-5. PubMed ID: 18275039
[TBL] [Abstract][Full Text] [Related]
3. Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
Hanke T; Lamers C; Gomez RC; Schneider G; Werz O; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3757-63. PubMed ID: 25037914
[TBL] [Abstract][Full Text] [Related]
4. Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists.
Popescu L; Rau O; Böttcher J; Syha Y; Schubert-Zsilavecz M
Arch Pharm (Weinheim); 2007 Jul; 340(7):367-71. PubMed ID: 17610302
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists.
Carrieri A; Giudici M; Parente M; De Rosas M; Piemontese L; Fracchiolla G; Laghezza A; Tortorella P; Carbonara G; Lavecchia A; Gilardi F; Crestani M; Loiodice F
Eur J Med Chem; 2013 May; 63():321-32. PubMed ID: 23502212
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Okazaki S; Shioi R; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
Bioorg Med Chem; 2016 Nov; 24(21):5455-5461. PubMed ID: 27622746
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.
Kumar R; Ramachandran U; Khanna S; Bharatam PV; Raichur S; Chakrabarti R
Bioorg Med Chem; 2007 Feb; 15(3):1547-55. PubMed ID: 17166722
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175.
Piemontese L; Fracchiolla G; Carrieri A; Parente M; Laghezza A; Carbonara G; Sblano S; Tauro M; Gilardi F; Tortorella P; Lavecchia A; Crestani M; Desvergne B; Loiodice F
Eur J Med Chem; 2015 Jan; 90():583-94. PubMed ID: 25497132
[TBL] [Abstract][Full Text] [Related]
9. Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator.
Thieme TM; Steri R; Proschak E; Paulke A; Schneider G; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2010 Apr; 20(8):2469-73. PubMed ID: 20307981
[TBL] [Abstract][Full Text] [Related]
10. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity.
Fracchiolla G; Lavecchia A; Laghezza A; Piemontese L; Trisolini R; Carbonara G; Tortorella P; Novellino E; Loiodice F
Bioorg Med Chem; 2008 Nov; 16(21):9498-510. PubMed ID: 18835719
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
Bernardes A; Souza PC; Muniz JR; Ricci CG; Ayers SD; Parekh NM; Godoy AS; Trivella DB; Reinach P; Webb P; Skaf MS; Polikarpov I
J Mol Biol; 2013 Aug; 425(16):2878-93. PubMed ID: 23707408
[TBL] [Abstract][Full Text] [Related]
13. Pirinixic acids: flexible fatty acid mimetics with various biological activities.
Merk D; Zettl M; Steinhilber D; Werz O; Schubert-Zsilavecz M
Future Med Chem; 2015 Aug; 7(12):1597-616. PubMed ID: 26313377
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Asaki T; Aoki T; Hamamoto T; Sugiyama Y; Ohmachi S; Kuwabara K; Murakami K; Todo M
Bioorg Med Chem; 2008 Jan; 16(2):981-94. PubMed ID: 17964792
[TBL] [Abstract][Full Text] [Related]
15. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
Niu H; Wang W; Li J; Lei Y; Zhao Y; Yang W; Zhao C; Lin B; Song S; Wang S
Eur J Med Chem; 2017 Sep; 138():212-220. PubMed ID: 28667876
[TBL] [Abstract][Full Text] [Related]
16. [Design, synthesis, and PPARalpha/gamma agonistic activity of novel tetrahydroisoquinoline derivatives].
Yu R; Zhou YL; Huan Y; Liu Q; Shen ZF; Liu ZZ
Yao Xue Xue Bao; 2011 Mar; 46(3):311-6. PubMed ID: 21626786
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-activity relationship of carbamate-tethered aryl propanoic acids as novel PPARalpha/gamma dual agonists.
Kim NJ; Lee KO; Koo BW; Li F; Yoo JK; Park HJ; Min KH; Lim JI; Kim MK; Kim JK; Suh YG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3595-8. PubMed ID: 17507225
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of a novel series of alpha-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) alpha/delta dual agonists for the treatment of metabolic syndrome.
Kasuga J; Yamasaki D; Araya Y; Nakagawa A; Makishima M; Doi T; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2006 Dec; 14(24):8405-14. PubMed ID: 16996742
[TBL] [Abstract][Full Text] [Related]
19. New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression.
Laghezza A; Pochetti G; Lavecchia A; Fracchiolla G; Faliti S; Piemontese L; Di Giovanni C; Iacobazzi V; Infantino V; Montanari R; Capelli D; Tortorella P; Loiodice F
J Med Chem; 2013 Jan; 56(1):60-72. PubMed ID: 23171045
[TBL] [Abstract][Full Text] [Related]
20. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE
J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
